Faculty profile

Christina Greenaway

ResearcherMedicine/MicrobiologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Christina Greenaway

Researcher

Medicine/Microbiology

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
29 publications in the last five years, latest in 2026.
Senior (last) author on 9 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2024.
Supervised 2 trainees who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Health Disparities Immigrants Health Equity Hepatitis B Virus Infection Immigrants And Newcomers Implementation Science Linkage To Care People Who Use Drugs

Latest papers

Effect of hepatitis C virus treatment engagement on the skin and soft tissue infections healthcare burden among people who inject drugs in Quebec, Canada: a population-based interrupted time series study.
The International journal on drug policy · 2026
Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).
Implementation science communications · 2026
Health care providers' perspectives on barriers and enablers to providing hepatitis C screening and treatment for immigrants in Canada: A theory-informed qualitative study.
Canadian liver journal · 2026

All 69 publications

Latest funding

Improving hepatitis B testing, linkage to care, and treatment for immigrants in Canada: a mixed-methods implementation science study across British Columbia, Ontario, and Québec
CIHR · 2025 · Supervisor
$120,000
Getting to hepatitis B elimination in Canada: Where are the gaps and how best to fill them?
CIHR · 2024 · Nominated PI
$1,239,300
Establishing the Framework for Decentralized Hepatitis C Point-of-Care Testing and Treatment in Canada: An Implementation Science-based Approach
CIHR · 2024 · Co-investigator
$656,371

All 9 grants and awards

69 publications.

Effect of hepatitis C virus treatment engagement on the skin and soft tissue infections healthcare burden among people who inject drugs in Quebec, Canada: a population-based interrupted time series study.

El Sheikh MZ, Panagiotoglou D, Greenaway C, Klein MB

The International journal on drug policy2026

DOI: 10.1016/j.drugpo.2026.105335 PMID: 42166850

Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Mooney M, Weight C, Biondi MJ, Grebely J, Kronfli N, Barnett T, Bruneau J, Dunn K, Elakpa DN, Etherington C, Greenaway C, Martel-Laferrière V, Mendlowitz A, Taylor N, Fontaine G

Implementation science communications2026

DOI: 10.1186/s43058-026-01014-w PMID: 42310812

Health care providers' perspectives on barriers and enablers to providing hepatitis C screening and treatment for immigrants in Canada: A theory-informed qualitative study.

Mortazhejri S, Greenaway C, Cooper C, Pakhale S, Presseau J, Grimshaw JM, Patey AM

Canadian liver journal2026

DOI: 10.3138/canlivj-2025-0045 PMID: 42404989

Improving the tuberculosis infection care cascade among migrants in Canada: a cost-effectiveness modelling study.

Fournier AL, Nsengiyumva NP, Jordan A, Mappin-Kasirer B, AbouNader K, Greenaway C, Campbell JR, Schwartzman K

The Lancet. Public health2026

DOI: 10.1016/s2468-2667(25)00300-7 PMID: 41611368

Interventions facilitating access to perinatal care for migrant women without medical insurance: a scoping review.

Sia D, Beogo I, Ntanda GM, Tchouaket Nguemeleu E, Bationo NJ, Séguin C, Roch G, Greenaway C

PloS one2026Senior author

DOI: 10.1371/journal.pone.0357487 PMID: 42721192

Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Mooney M, Weight C, Biondi MJ, Grebely J, Kronfli N, Barnett T, Bruneau J, Dunn K, Elakpa DN, Etherington C, Greenaway C, Martel-Laferrière V, Mendlowitz A, Taylor N, Fontaine G

Implementation science communications2025

DOI: 10.1186/s43058-025-00837-3 PMID: 41408357

Effect of sustained virologic response on liver-related mortality among individuals living with hepatitis C by treatment era: A population-based retrospective cohort study.

Erman A, Everett K, Wong WWL, Forouzannia F, Greenaway C, Janjua N, Kwong JC, Sander B

PloS one2025

DOI: 10.1371/journal.pone.0333584 PMID: 41052060

Perceptions about hepatitis C and barriers and enablers to screening and treatment among Egyptian immigrants to Canada: a theory-informed qualitative study.

Mortazhejri S, Thomas IM, Patey AM, Alghamyan A, Cooper C, Mansour S, Pakhale S, Presseau J, Grimshaw JM, Greenaway C

International journal for equity in health2025Senior author

DOI: 10.1186/s12939-025-02582-4 PMID: 40646616

Estimated prevalence of hepatitis B and C among immigrants in Canada.

Campeau L, Elliott J, Williams A, Périnet S, Yang Q, Cox J, Feld JJ, Greenaway C, Popovic N

Canada communicable disease report = Releve des maladies transmissibles au Canada2025

DOI: 10.14745/ccdr.v51i67a01 PMID: 40861919

The urgent need for implementation science to achieve hepatitis C elimination.

Fontaine G, Taylor N, Bruneau J, Kronfli N, Greenaway C, Biondi MJ, Klein MB, Saeed S, Grebely J, Presseau J

The lancet. Gastroenterology & hepatology2025

DOI: 10.1016/s2468-1253(25)00050-0 PMID: 40054488

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Health Disparities Dear Professor Greenaway, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Effect of hepatitis C virus treatment engagement on the skin and soft tissue infections healthcare burden among people who inject drugs in Quebec, Canada: a population-based interrupted time series study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Getting to hepatitis B elimination in Canada: Where are the gaps and how best to fill them?" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Christina Greenaway

Research

Latest papers

Latest funding

Effect of hepatitis C virus treatment engagement on the skin and soft tissue infections healthcare burden among people who inject drugs in Quebec, Canada: a population-based interrupted time series study.

Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Health care providers' perspectives on barriers and enablers to providing hepatitis C screening and treatment for immigrants in Canada: A theory-informed qualitative study.

Improving the tuberculosis infection care cascade among migrants in Canada: a cost-effectiveness modelling study.

Interventions facilitating access to perinatal care for migrant women without medical insurance: a scoping review.

Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).

Effect of sustained virologic response on liver-related mortality among individuals living with hepatitis C by treatment era: A population-based retrospective cohort study.

Perceptions about hepatitis C and barriers and enablers to screening and treatment among Egyptian immigrants to Canada: a theory-informed qualitative study.

Estimated prevalence of hepatitis B and C among immigrants in Canada.

The urgent need for implementation science to achieve hepatitis C elimination.

Frequent collaborators

Beate Sander

Kevin Pottie

Andrea Benedetti

Andrea Benedetti

Kevin Schwartzman

Julie Bruneau

Laurent Azoulay

Laurent Azoulay

Naveed Janjua

Ian Shrier

Dimitra Panagiotoglou

Guillaume Fontaine

Guillaume Fontaine

Charles Hui

Nadine Kronfli

Justin Presseau

Vivian Welch

Kate Dunn

Smita Pakhale

Lauren Lapointe-Shaw

Cole Etherington

Cecile Rousseau

Andrew Mendlowitz

Tamara Barnett

Cecile Rousseau

Madhukar Pai

Marina Klein

Sara Ahmed

Curtis Cooper

Ana Duggan

Peter Tugwell

Jeffrey (Des) Pernica